Topical timolol maleate 0.5% for infantile capillary haemangioma of the eyelid

British Journal of Ophthalmology

Volumn 96, Issue 12, 2012, Pages 1536-1537

  Xue, Kanmin ^a,b   Hildebrand, Göran Darius ^a,b  

^a KING EDWARD VII HOSPITAL   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL; TIMOLOL MALEATE;

BRADYCARDIA; BRONCHOSPASM; CAPILLARY HEMANGIOMA; DRUG ABSORPTION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EYELID TUMOR; HUMAN; HYPOCALCEMIA; HYPOTENSION; LETTER; PRIORITY JOURNAL; SLEEP DISORDER;

ADRENERGIC BETA-ANTAGONISTS; EYELID NEOPLASMS; HEMANGIOMA, CAPILLARY; HUMANS; ORBITAL NEOPLASMS; PROPRANOLOL;

EID: 84869864682     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302396     Document Type: Letter

References (6)

1. Thoumazet F, Léauté-Labrèze C, Colin J, et al. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients. Br J Ophthalmol 2012;96:370-4.
2. Ni N, Langer P, Wagner R, et al. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol 2011;129:377-9.
3. Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012;29:28-31.
4. Chambers CB, Katowitz WR, Katowitz JA, et al. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas. Ophthal Plast Reconstr Surg 2012;28:103-6.
5. Stamatas GN, Nikolovski J, Mack MC, et al. Infant skin physiology and development during the first years of life: a review of recent findings based on in vivo studies. Int J Cosmet Sci 2011;33:17-24.
6. Achong MR, Piafsky KM, Ogilvie RI. Comparison of cardiac effects of timolol and propranolol. Clin Pharmacol Ther 1975;18:278-86.